openPR Logo
Press release

BIOCHINA2026 - Fusion Forward: Uniting the Global Biopharma Community in Suzhou

11-14-2025 05:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: SHENZHEN HMEDIUM INFORMATION TECHNOLOGY CO.,LTD
BIOCHINA2026 - Fusion Forward: Uniting the Global Biopharma

Suzhou, China - The global biopharmaceutical industry will gather in Suzhou as BIOCHINA2026 returns for its 11th edition under the theme "Fusion Forward." Recognized as one of Asia's most influential platforms, BIOCHINA provides a premier venue for scientific discussion, industry insights, and strategic collaboration.

Image: https://www.globalnewslines.com/uploads/2025/11/e1e67f77b8e654bcdc7afa2b21c2cbae.jpg

The conference is expected to welcome over 30,000 professionals from 40+ countries and regions, including 500+ international delegates. 250 specialized forums will feature 850+ speakers sharing insights on early-stage R&D innovation, global clinical development, manufacturing technologies, regulatory submissions and technology transfer, project collaboration, market access, and capital strategies.

Featured exhibitors: Hanbon Science and TechnologySunresin New MaterialsDuoning BiotechLisure ScienceInscinstechChallenge IMBaiSifeiGenScript BiotechnologyProBioPharmasyntezMorimatsu Life ScienceChempartner PharmatechSepax TechnologiesNanomicro Technology

Part of confirmed participating pharmaceutical companies: Hengrui Medicine, Qilu Pharmaceutical, CSPC Pharmaceutical Group, Zai Lab, Junshi Biosciences, Duality Biologics, Sino Biopharm, Lilly, Novartis, Merck & Co., Bayer, Fosun Kairos, JW Therapeutics, CARsgen, Juventas Cell Therapy, BeOne Medicines, Henlius, Lepu Biopharma, Gan & Lee Pharmaceuticals, Huadong Medicine, Livzon Group, Bio-Thera Solutions, Imunopharm, C Ray Therapeutics, Daiichi Sankyo, Takeda, Innovant Bio, BinnoPharma, Geropharma, Celltrion, Eurofarma.

BIOCHINA Exhibition

400+ Premium Exhibitors Gather! Building a Full-Industry Exchange & Collaboration Platform

Image: https://www.globalnewslines.com/uploads/2025/11/ba2b88fc69a959736f2904aa3fb19d5b.jpg

Exhibition Halls: Laboratory Instruments, Pharma Equipment, Raw Materials & Reagents, International Services, Consumables, Integrated Solutions.

Exhibitors: 400+ top Chinese and international companies.

Full-Chain Solutions: From R&D to commercialization.

Global Collaboration: Seamless cross-regional and industry partnerships.

Professional Ecosystem: Procurement, networking, and cooperation in one platform.

BIOCHINA Forum

250 Professional Forums and 850+ Leading Speakers Drive Industry Integration and Global Leadership

Image: https://www.globalnewslines.com/uploads/2025/11/09d807dfa0042626148031a5a2540f17.jpg

Image: https://www.globalnewslines.com/uploads/2025/11/4576070946b66564b60d592ff38a29bb.jpg

Formats: Forums, brainstorming sessions, closed-door meetings, roadshows, and the central stage.

Three Pillars: Executive Strategy & Collaboration, Full-Cycle Biopharma Tracks, New Technologies & Hot Topics.

Executive Strategy Forum: Capital, partnerships, and global CEO networking.

Full-Cycle Biopharma Tracks Forum: Key biopharma areas across the entire value chain.

New Technologies & Hot Topics Forum: Cutting-edge trends including AI, in vivo CAR-T, CMC globalization, and exosomes.

BIOCHINA International

500+ international delegates from 40+ countries and regions, creating global connections and opportunities.

Image: https://www.globalnewslines.com/uploads/2025/11/f5ee2745ce7503e102917fa13d9ddfec.jpg

BIOCHINA 2025 welcomes participants from 40+ countries and regions.

It covers key markets in Japan, South Korea, Asia, Europe, the Americas, Russia, India, the Middle East, Latin America, Southeast Asia, and Belt & Road regions.

Companies from around the world will actively participate.

The event features forums, Exhibition, 1V1 BiOPartnering meetings, and networking receptions.

BIOCHINA 2025 offers opportunities to expand markets and connect global resources.

BiOPartnering

Next-Level, Linking the World in a Single Space

Image: https://www.globalnewslines.com/uploads/2025/11/f4ce78343e38884a8b60b1fa8b24377d.jpg

BIOCHINA connects the global biopharma community through 30-minute 1V1 meetings and 3,000 targeted conversations.Four Partnering room types improve brand exposure and matchmaking efficiency.Multinational pharma, top investors, innovative biotech, and academic leaders come together.The platform drives global investment, strategic partnerships, and key conversations.

BIOCHINA2026 - Fusion Forward underscores China's role as a global hub for biopharmaceutical innovation and its commitment to advancing industry collaboration.

Agenda: https://static.biocn.cn/file/BIOCHINA2026_Agenda.pdf

Registrationhttps://u.morebio.cn/JZr2qiVU

About BIOCHINA

BIOCHINA 2026 (11th) will be held from March 12-14 at the Suzhou International Expo Center. Following the success of BIOCHINA 2025 (10th), which welcomed 30,000 attendees in Suzhou, BIOCHINA continues its journey of boundless innovation and collaborative growth

Over the past decade, BIOCHINA has expanded from China's thriving biopharmaceutical sector to the world stage, establishing an international platform for industry connectivity and uniting global expertise to advance collaboration. Through technological breakthroughs, commercial implementation, capital support, and ecosystem integration, BIOCHINA has witnessed China's innovative drug industry evolve from following to leading, progressing alongside the industry and the times.

BIOCHINA2026 Fusion & Forward 'Fusion' embodies the power of an ecosystem, where diverse forces converge to unlock growth. 'Forward' represents future direction, pushing boundaries to define new heights for the industry. Standing at the threshold of a new decade, BIOCHINA 2026 will join hands with global partners to step into the next golden era of China's biopharmaceutical industry.

About Organizer

Enmore Bio is China's leading biopharmaceutical communication and collaboration platform. We integrate exhibitions, conferences, BioBD&BiOFUNDING matchmaking, online services, and customized membership programs, connecting the global healthcare and life sciences ecosystem and driving innovation and collaboration.

Contact:

WhatsApp: +86 156 1892 1630

LinkedIn: https://www.linkedin.com/company/biochina/?viewAsMember=true
Media Contact
Company Name: Enmore BIO
Contact Person: Cathy Yuan
Email: Send Email [http://www.universalpressrelease.com/?pr=biochina2026-fusion-forward-uniting-the-global-biopharma-community-in-suzhou]
Country: China
Website: https://www.biocn.cn/en/en.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BIOCHINA2026 - Fusion Forward: Uniting the Global Biopharma Community in Suzhou here

News-ID: 4271641 • Views:

More Releases from Getnews

Travel China; Expert-Guided Tours & Asia Travel Packages for 2026
Travel China; Expert-Guided Tours & Asia Travel Packages for 2026
Image: https://www.globalnewslines.com/uploads/2025/11/1763110098.jpg The Asia-Pacific region is experiencing unprecedented tourism renaissance. International visitor arrivals reached 295.7 million in the first half of 2025-a 5.4% year-on-year increase and 92.6% recovery to pre-2019 levels. This surge reflects a fundamental shift in how travelers approach exploration: authentic experiences, expert guidance, and purposeful travel now dominate conventional tourism. China, Japan and Thailand drive this growth. Travel to Asia in 2025 was up 41% over the previous year,
Spain-Real.Estate introduces a smarter way for clients to find their dream homes in Spain
Spain-Real.Estate introduces a smarter way for clients to find their dream homes …
Image: https://www.globalnewslines.com/uploads/2025/11/1763109849.jpg Spain-Real.Estate [https://spain-real.estate/] has officially launched - a next-generation online property platform connecting international buyers with verified listings across Spain's most desirable destinations. Designed for transparency, convenience, and global accessibility, the platform unites thousands of offers from reputable developers and agencies in one intuitive digital space. The service is tailored for a broad audience, from those searching for a coastal retreat to investors seeking long-term opportunities in one of Europe's most
Nucore Health Launches Nationwide, Patient-Centered Platform for Advanced Personalized Wellness and Medication Delivery
11-14-2025 | Health & Medicine
Getnews
Nucore Health Launches Nationwide, Patient-Centered Platform for Advanced Person …
Detroit, MI - November 14, 2025 - Nucore Health, a technology-driven healthcare company, has announced the nationwide rollout of its fully integrated digital platform that connects patients with a network of licensed physicians and compound pharmacies across the United States. Nucore Health enables patients to access customized therapies for weight loss, growth hormone support, longevity, and energy without an in-person clinic visit and with medications shipped directly to patients' homes. Image:
PKU Pioneer Commissions VPSA Oxygen Plant for Blast Furnace Oxygen Enrichment, Slashing Steel Mill's Annual Costs by $4.5 Million
PKU Pioneer Commissions VPSA Oxygen Plant for Blast Furnace Oxygen Enrichment, S …
Recently, the second-phase 14,000 Nm/h pressure swing adsorption (VPSA) oxygen generation facility, constructed by Beijing Peking University Pioneer Technology Co., Ltd. (hereinafter referred to as "PKU Pioneer") for Chifeng Yuanlian Iron and Steel Co., Ltd. (hereinafter referred to as "Chifeng Yuanlian"), has successfully commissioned and achieved stable oxygen supply. With this milestone, Chifeng Yuanlian's total VPSA oxygen generation capacity reaches 28,000 Nm/h, significantly reducing the cost of blast furnace oxygen

All 5 Releases


More Releases for BIO

Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the